Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14 | 10 | 26 | 80 | 45 |
| TOTAL | $14 | $10 | $26 | $80 | $45 |
| Non-Current Assets | |||||
| Intangibles | 115 | 116 | 113 | 109 | 98 |
| TOTAL | $115 | $116 | $113 | $109 | $98 |
| Total Assets | $129 | $126 | $139 | $189 | $143 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 433 | 210 | 330 | 378 | 763 |
| Other current liabilities | 65 | 44 | 1,015 | 55 | 6 |
| TOTAL | $1,229 | $1,116 | $3,244 | $2,333 | $2,769 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 13 | 22 | 35 | 1 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,229 | $1,116 | $3,244 | $2,333 | $2,769 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 177,956 | 174,963 | 166,493 | 144,642 | 132,535 |
| Common Shares | 177 | 173 | 145 | 144 | 132 |
| Retained earnings | -16,960 | -16,298 | -15,699 | -14,451 | -13,414 |
| Other shareholders' equity | -694 | -694 | -636 | -659 | -624 |
| TOTAL | $-1,100 | $-990 | $-3,105 | $-2,144 | $-2,626 |
| Total Liabilities And Equity | $129 | $126 | $139 | $189 | $143 |